Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Case Comprehensive Cancer Center
Thomas Jefferson University
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Indiana University
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Alliance for Clinical Trials in Oncology
Gruppo Italiano Malattie EMatologiche dell'Adulto
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Case Comprehensive Cancer Center
Rush University Medical Center
Rutgers, The State University of New Jersey
Rutgers, The State University of New Jersey
First Affiliated Hospital Xi'an Jiaotong University
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Fred Hutchinson Cancer Center
University of Chicago
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
University of Maryland, Baltimore
Stanford University
Northwestern University
Stanford University
Stanford University
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Wake Forest University Health Sciences
University of Washington
Alliance for Clinical Trials in Oncology
Stanford University
University of Southern California
Fundació Sant Joan de Déu
The Cleveland Clinic
Masonic Cancer Center, University of Minnesota
Stanford University
Fred Hutchinson Cancer Center
Gruppo Italiano Malattie EMatologiche dell'Adulto
Fred Hutchinson Cancer Center
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
University of Alberta
Fred Hutchinson Cancer Center